2021-06-30 09:51:54 BdST
Moderna Covid shots authorised for emergency use in Bangladesh
The Directorate General of Drug Administration on Tuesday night approved emergency use of Covid-19 vaccine Moderna in the country.
The regulator has given Emergency Use Authorisation (EUA) after all necessary examinations by the technical committee, a press release of DGDA said.
According to the DGDA, Moderna is the eighth vaccine to be given the EUA.
On June 15, DGDA approved emergency use of Johnson & Johnson's Covid-19 vaccine "Janssen" in Bangladesh.
On June 3, the Directorate General of Drug Administration (DGDA) approved the Chinese Covid-19 vaccine "CoronaVac", manufactured by Sinovac Life Sciences Company Limited.
On May 27, the DGDA approved emergency use of the Pfizer mRNA Covid-19 vaccine in the country.
Bangladesh has so far approved eight Covid-19 vaccines to control the deadly disease.
These vaccines are Covid-19 vaccine Moderna, Johnson & Johnson, "CoronaVac", manufactured by Sinovac Life Sciences Company Limited, Pfizer mRNA Covid-19 vaccine, Covishield produced by Serum Institute of India; Sputnik V manufactured by Generium Joint Stock Company of Russia, AstraZeneca manufactured by Sweden and Sinopharm produced by Beijing Institute of Biological Products Co Ltd of China.
Unauthorized use or reproduction of The Finance Today content for commercial purposes is strictly prohibited.